Skip to main content
Equibles

VOYA INVESTMENT MANAGEMENT LLC

Position in NEO — Neogenomics Inc

CIK 1068837 ATLANTA, GA
Back to NEO Full portfolio

Position in NEO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$962,429
-$933,039 QoQ
Shares Held
65,965
-74.2% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $921,246,084 across 28 Diagnostics & Research names. NEO ranks #22 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 WAT
Waters Corp /De/
 653,967 $245,263,782
2 DHR
Danaher Corp /De/
 732,006 $139,432,501
3 TMO
Thermo Fisher Scientific Inc.
 257,632 $129,166,378
4 GH
Guardant Health, Inc.
 480,839 $72,140,274
5 NTRA
Natera, Inc.
 252,610 $68,570,983
6 IDXX
Idexx Laboratories Inc /De
 95,942 $50,507,705
7 ICLR
Icon PLC
 289,918 $50,361,655
8 DGX
Quest Diagnostics Inc
 211,496 $44,826,576

All Filings in NEO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $962,429 65,965
2026-03-31 $1,895,468 255,454
2025-12-31 $3,350,258 284,886
2025-09-30 $182,933 23,696
2025-06-30 $258,013 35,296
2025-03-31 $327,898 34,552
2024-12-31 $1,016,618 61,688
2024-09-30 $956,478 64,846
2024-06-30 $913,450 65,858
2024-03-31 $975,237 62,038
2023-12-31 $1,003,418 62,016
2023-09-30 $2,868,371 233,201
2023-06-30 $986,248 61,372
2023-03-31 $1,022,193 58,713
2022-12-31 $692,473 74,943
2022-09-30 $645,259 74,943
2022-06-30 $756,214 92,787
2022-03-31 $1,111,834 91,509
2021-12-31 $2,870,856 84,140
2021-09-30 $4,083,950 84,659
2021-06-30 $3,769,843 83,459
2021-03-31 $4,193,936 86,957
2020-12-31 $4,043,814 75,108
2020-09-30 $2,144,341 58,128
2020-06-30 $1,821,902 58,809
2020-03-31 $1,938,498 70,210